Koyfin Home > Directory > Health Care > Amicus Therapeutics > Repurchase of Common Stock

Amicus Therapeutics Repurchase of Common Stock Chart (FOLD)

Amicus Therapeutics annual/quarterly Repurchase of Common Stock from 2009 to 2018.
  • Amicus Therapeutics Repurchase of Common Stock for the quarter ending September 09, 2018 was $-1m a 19.11% decrease of 0m year over year
  • Amicus Therapeutics Repurchase of Common Stock for the last 12 months ending September 09, 2018 was $-3m a 50.28% decrease of -2m year over year
  • Amicus Therapeutics Annual Repurchase of Common Stock for 2017 was $-2m a 19.67% decrease of 0m from 2016
  • Amicus Therapeutics Annual Repurchase of Common Stock for 2016 was $-1m a -59.44% increase of 1m from 2015
  • Amicus Therapeutics Annual Repurchase of Common Stock for 2015 was $-2m
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Repurchase of Common Stock Data

09/2018$-1m
06/2018$0m
03/2018$-2m
12/2017$-1m
09/2017$0m
06/2017$-1m
03/2017$0m
12/2016$0m
09/2016$0m
03/2016$-1m

Annual FOLD Repurchase of Common Stock Data

2017$-2m
2016$-1m
2015$-2m